DICE THERAPEUTICS, INC. (a Delaware corporation) [•] Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • September 9th, 2021 • DiCE MOLECULES HOLDINGS, LLC • Pharmaceutical preparations • New York
September 7, 2021 Scott Robertson via email Dear Scott:Offer Letter • September 9th, 2021 • DiCE MOLECULES HOLDINGS, LLC • Pharmaceutical preparations
This letter agreement amends and restates the offer letter between you and DICE Therapeutics, Inc. (the “Company”)1, dated March 26, 2016 (the “Prior Agreement”) effective [ ]2, 2021.
FIFTH AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF DICE MOLECULES HOLDINGS, LLC (a Delaware limited liability company)Limited Liability Company Agreement • September 9th, 2021 • DiCE MOLECULES HOLDINGS, LLC • Pharmaceutical preparations • Delaware
CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • September 9th, 2021 • DiCE MOLECULES HOLDINGS, LLC • Pharmaceutical preparations • California
This Change in Control and Severance Agreement (the “Agreement”) is entered into by and between [Name] (the “Executive”) and DICE Therapeutics, Inc., a Delaware corporation (the “Company”), effective as of (the “Effective Date”).
